A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis Suppurativa
Status:
Not yet recruiting
Trial end date:
2025-03-06
Target enrollment:
Participant gender:
Summary
This is a Phase 2 study in adult participants with moderate to severe hidradenitis
suppurativa (HS). The purpose of the study is to evaluate the efficacy and safety of
SAR442970 compared to placebo.